Physician profile
Christopher D Dobrose
NPI 1871564666
$6,856.65
in general payments reported to CMS, 2019-2025
50 companies · $997 in 2025
The $997 reported for 2025 was more than what 86% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $679 · 2020: $628 · 2021: $1,134 · 2022: $874 · 2023: $1,333 · 2024: $1,211 · 2025: $997.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,541.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,540.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,297.73 | 2021-2025 | Ubrelvy, Vraylar, Qulipta |
| Astrazeneca Pharmaceuticals LP | $1,098.29 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Amgen INC. | $559.92 | 2019-2025 | Otezla, Repatha, Evenity |
| Pfizer INC. | $516.46 | 2019-2024 | |
| Novo Nordisk INC | $409.06 | 2019-2025 | Rybelsus, Ozempic |
| Lilly USA, LLC | $331.25 | 2019-2025 | Mounjaro, Zepbound, Trulicity |
| Allergan, INC. | $236.11 | 2019-2020 | |
| Dexcom, INC. | $216.18 | 2021-2025 | Dexcom G6 Transmitter |
| Medtronic, INC. | $211.01 | 2025 | Inceptiv |
| Smith+Nephew, INC. | $185.31 | 2019-2024 | Collagenase Santyl |
| Tactile Systems Technology INC | $135.01 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $116.58 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $116.16 | 2019-2024 | Jardiance |
| Antares Pharma, INC. | $102.72 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $102.59 | 2019-2024 | Xifaxan |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $101.20 | 2022-2025 | Nuzyra |
| Shield Therapeutics INC | $67.65 | 2022-2023 | Accrufer |
| Glaxosmithkline, LLC. | $66.17 | 2022-2023 | Trelegy Ellipta, Arexvy, Shingrix |
| Reapplix INC. | $65.29 | 2025 | 3c Patch Kit - Box |
| Insulet Corporation | $57.32 | 2023 | Omnipod |
| Otsuka America Pharmaceutical, INC. | $55.28 | 2023-2025 | Rexulti, Nuedexta |
| Exact Sciences Corporation | $52.35 | 2023-2025 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $48.75 | 2019-2020 | |
| Xeris Pharmaceuticals, INC. | $43.54 | 2022-2023 | Gvoke Hypopen |
| Novartis Pharmaceuticals Corporation | $41.96 | 2022-2024 | |
| Genentech USA, INC. | $41.92 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $38.32 | 2019 | |
| Amarin Pharma, INC. | $38.02 | 2020-2021 | |
| Biohaven Pharmaceuticals, INC. | $37.88 | 2021 | |
| Kci USA, INC. | $37.28 | 2021-2023 | Promogran Prisma, V.A.C. Dermatac, 3m Coban |
| Biohaven Pharmaceutical Holding Company LTD. | $35.64 | 2022 | |
| Abbott Laboratories | $33.83 | 2021 | |
| Astellas Pharma US INC | $30.29 | 2022-2023 | Veozah |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $30.18 | 2024-2025 | Caplyta |
| E.R. Squibb & Sons, L.L.C. | $29.08 | 2021-2024 | Camzyos |
| Kerecis Limited | $27.97 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Sequel Med Tech, LLC | $23.30 | 2025 | Twiist |
| Lundbeck LLC | $21.52 | 2023 | Rexulti |
| Supernus Pharmaceuticals, INC. | $20.88 | 2019 | |
| Advanced Oxygen Therapy INC. | $19.20 | 2025 | Topical Oxygen Chamber For Extremities |
| Si-Bone, INC. | $18.94 | 2021 | |
| Integra Lifesciences Corporation | $18.58 | 2023 | Tcc-Ez |
| Phathom Pharmaceuticals, INC. | $17.59 | 2024 | Voquezna |
| Edwards Lifesciences Corporation | $17.35 | 2022 | |
| Biomarin Pharmaceutical INC. | $16.88 | 2024 | Voxzogo 1.2mg |
| Cipher Pharmaceuticals US LLC | $15.16 | 2025 | Natroba, Spinosad |
| Axsome Therapeutics, INC. | $15.14 | 2025 | Symbravo |
| Reprise Biomedical, INC. | $13.68 | 2025 | Miro3d |
| Esperion Therapeutics, INC. | $12.40 | 2021 | |
| Scynexis, INC. | $11.73 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Dobrose listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.